The importance of pharmacokinetics in determining the relative potency of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2,3,7,8-tetrachlorodibenzofuran

Toxicological Sciences

Volumn 24, Issue 1, 1995, Pages 145-148

  Devito, Michael J ^a   Birnbaum, Linda S ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 2,3,7,8 TETRACHLORODIBENZOFURAN; ETHOXYRESORUFIN DEETHYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; FEMALE; LIVER; MOUSE; NONHUMAN; PHARMACOKINETICS; SKIN; TOXICOKINETICS;

ANIMALIA; ERAGROSTIS TEF;

EID: 77957181770     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/24.1.145     Document Type: Article

References (13)

1. Barnes, D., Alford-Stevens, A., Bimbaum, L., Kutz, F. W., and Patton, D. (1991). Toxicity equivalency factors for PCBs? Qual. Assur. Good Practice Regul. Law 1, 70-81.
2. Bimbaum, L. S. (1986). Distribution and excretion of 2,3,7,8-tetrachloro-dibenzo-p-dioxin in congenic strains of mice which differ at the Ah locus. Drug Metab. Dispos. 14, 34-40.
3. Couture, L. A., Elwell, M. R., and Bimbaum, L. S. (1988). Dioxin-like effects observed in male rats following exposure to octachlorodibenzo-p-dioxin (OCDD) during a 13 week study. Toxicol. Appl Pharmacol 93, 31-42.
4. Decad, G. M., Bimbaum, L. S., and Matthews, H. B. (1981). Distribution and excretion of 2,3,7,8-tetrachlorodibenzofuran in C57B1/6J and DBA/2J mice. Toxicol. Appl. Pharmacol. 59, 564-573.
5. Devito, M. J., Maier, W. E., Diliberto, J. J., and Bimbaum, L. S. (1993). Comparative ability of various PCBs, PCDFs and TCDD to induce cytochrome P-450 1A1 and 1A2 activity following 4 weeks of treatment. Fundam. Appl. Toxicol. 20, 125-130.
6. Devito, M. J., Ma, X., Babish, J. G., Menache, M., and Bimbaum, L. S. (1994). Dose-response relationships in mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: CYP1A1, CYP1A2, estrogen receptor and protein tyrosine phosphorylation. Toxicol. Appl. Pharmacol. 124, 82-90.
7. Eadon, G. L., Kaminisky, J., Silkworth, J., Aldous, D., Hilker, P., O’keefe, R., Gierthy, J., Hawley, K., Kim, N., and Decaprio, A. (1986). Calculation of 2,3,7,8-TCDD equivalent concentrations of complex environmental contaminant mixtures. Environ. Health Perspect. 70, 221-227.
8. Gasiewicz, T. A., Geiger, L. E., Rucci, G., and Neal, R. A. (1983). Distribution, excretion and metabolism of 2,3,7,8-tctrachlorodibenzo-p-dioxin in C57BL/6J, DBA/2J, and B6D2F1/J mice. Drug Melab Dispos. 11, 397-403.
9. Mason, G., Sawyer, T., Keys, B., Bandiera, S., Romkes, M., Piskorska-Pliszczynska, Smudzka, B., and Safe, S. (1985). Polychlorinated diben-zofurans (PCDFs): Correlation between in vivo and in vitro structure-ac-tivity relationships. Toxicology 35, 1-12.
10. McKinley, M. K., Kedderis, L. B., and Bimbaum, L. S. (1993). The effects of pretreatment on the biliary excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 2,3,7,8-tetrachlorodibenzofuran (TCDF) and 3,3',4,4'-tetrachlorobiphenyl, (TCB) in rats. Fundam. Appl. Toxicol. 21, 425-432.
11. Pohl, R. A., and Fouts, J. R. (1980). A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Anal. Biochem. 107, 150-155.
12. Safe, S. (1990). Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: Environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). CRC Crit. Rev. Toxicol. 21, 51-88.
13. USEPA (1989). Interim procedures for estimating risks associated with exposure to mixtures of chlorinated dibenzo-p-dioxins and-dibenzofur-ans (CDDs/CDFs, EPA/625-3-87/012).